West Lafayette, Ind.-based biopharmaceutical company Endocyte announced Feb. 24 that the company's folate-receptor biomarkers vintafolide and etarfolatide had orphan drug status and were moving closer to approval with a review by the European Committee for Medicinal Products for Human Use (CHMP).

The creation of a simple, computable summary performance measure for estimation of marginal values of new or supplementary imaging-based procedures is needed for the rapidly changing clinical environment, according to an article published in the March issue of Academic Radiology. 

Piramal Imaging announced today that F-18 florbetaben, also known as NeuraCeq, is cleared for commercial marketing by the European Commission.

Most breast cancers detected at screening ultrasonography were undetected at mammography, according to a study published in the February issue of Radiology. 

Not for another several months, the 2014 World Molecular Imaging Congress (WMIC) is scheduled to take Seoul, Korea, by storm from Sept. 17-20, but this week the Scientific Program Committee has made a formal request for abstracts to be submitted for presentation.

The European Congress of Radiology (ECR) in Vienna, the largest radiological conference throughout Europe, will be opening in less than two weeks from March 6-10 at the Austria Center Vienna, where it has now been held for 20 consecutive years.

The Toronto-based research group ADA Medical announced Feb. 14 that it would be collaborating with Ephoran Multi-Imaging Solutions in Turin, Italy, to provide preclinical imaging services.

A new whole-body MRI test that does not emit radiation could be an alternative to standard PET/CT imaging for cancer assessment in pediatric patients, according to a study published by The Lancet Oncology on Feb. 19.